Pyramid Pharma

Leading distributor of high-quality pharmaceuticals and medical supplies

Industry:

Medical Products

Region:

Africa

Website:

pyramidpharma.com

4,000,000 0

Customers

50 0 %

Emerging Consumers

32 0

Supplier Partners

Pyramid Group is a leading African distributor of specialist medical equipment and health products, combating a lack of access to medical resources and overburdened healthcare systems in Africa, as well as an increasing prevalence of diseases such as cancer and diabetes.

The Challenge

Africa currently has the highest age-standardised mortality rate of non-communicable diseases (779 per 100K people, versus US and EUR at 450-550 per 100K people).

Poor access to medical resources and over-burdened healthcare systems, as well as an increasing prevalence of noncommunicable diseases such as cancer and diabetes are driving a need for access to affordable new medicines and more advanced diagnostic equipment.

According to recent research, the African pharmaceutical market is set to reach $62bn by 2024, while the African medical devices market is set to reach $7bn by 2023, meaning that Pyramid is well positioned to deliver strong commercial and impact returns.

Pyramid's Solution

Pyramid Group is a leading distributor of specialist medical equipment and products that deliver the latest standard of care, access and affordability to Africans.

Founded in 2001, the company has grown to be the largest specialty distributor for cardiac and orthopaedic equipment in East Africa, offering a comprehensive range of quality medical products from top-tier brands including Medtronic Plc and Johnson & Johnson, opening-up access to specialised products like pacemakers and hip replacements for consumers in Africa who historically have had to travel abroad to access specialist products and treatments. This has contributed to the c.$1bn a year lost by Africa on medical tourism abroad.

The company currently provides healthcare products to four million consumers, of which over two million are emerging. Sales are projected to increase to approximately eight million total consumers over the next four years, of which over five million will be emerging.

LeapFrog's Impact

In 2018, LeapFrog invested in Pyramid Group, complementing our portfolio of healthcare partner companies.

The LeapFrog team is supporting business and operational improvements within the company, such as the cultivation of new customers using our in-house consumer insights capabilities.

Leveraging our deep healthcare expertise and strong pan-African networks, Pyramid Group is also seeking to expand its product lines and distribution, in order to supply more healthcare providers and extend the reach of its services across Africa.

Pyramid Pharma

4,000,000 0

50 0 %

32 0

The Challenge

The Challenge

Africa currently has the highest age-standardised mortality rate of non-communicable diseases (779 per 100K people, versus US and EUR at 450-550 per 100K people).

Pyramid's Solution

Pyramid's Solution

Pyramid Group is a leading distributor of specialist medical equipment and products that deliver the latest standard of care, access and affordability to Africans.

LeapFrog's Impact

LeapFrog's Impact

In 2018, LeapFrog invested in Pyramid Group, complementing our portfolio of healthcare partner companies.

Read more

How HealthifyMe uses AI to improve millions of lives with sustainable weight loss

Can AI transform impact investing?

'We must ensure impact lives up to its promise' - Karadogan

New LeapFrog fund to double down on financial services, healthcare

Expansion, investment key for MedGenome growth

IFC invests in new LeapFrog fund to bolster growth in health, fintech

How HealthifyMe uses AI to improve millions of lives with sustainable weight loss

Can AI transform impact investing?

'We must ensure impact lives up to its promise' - Karadogan

New LeapFrog fund to double down on financial services, healthcare

Expansion, investment key for MedGenome growth

IFC invests in new LeapFrog fund to bolster growth in health, fintech